# Nuclide record gastric-oesophageal-cancer (indication). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/indications/gastric-oesophageal-cancer/>
  a schema:MedicalCondition ;
  nuclide:kind "indication" ;
  schema:identifier "gastric-oesophageal-cancer" ;
  schema:name "Gastric and gastro-oesophageal junction adenocarcinoma"@en ;
  schema:alternateName "stomach cancer"@en, "gastric cancer"@en, "GEJ adenocarcinoma"@en, "oesophagogastric adenocarcinoma"@en ;
  schema:description "Cancer of the stomach or the junction where the gullet meets the stomach is common worldwide and still mostly found late, which is why survival is poor for most patients. Treatment now depends heavily on testing the tumour for a handful of markers that decide which targeted drugs and immunotherapies can be used."@en ;
  schema:url <https://nuclide.cc/indications/gastric-oesophageal-cancer/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://gco.iarc.who.int/media/globocan/factsheets/cancers/7-stomach-fact-sheet.pdf>, <https://seer.cancer.gov/statfacts/html/stomach.html>, <https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq>, <https://pubmed.ncbi.nlm.nih.gov/30982686/>, <https://www.nejm.org/doi/full/10.1056/NEJMoa1112088>, <https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-zolbetuximab-clzb-chemotherapy-gastric-or-gastroesophageal-junction-adenocarcinoma> ;
  nuclide:tag "gastrointestinal", "biomarker-selected", "peritoneal staging" ;
  nuclide:related <https://nuclide.cc/targets/cldn18-2/>, <https://nuclide.cc/targets/her2/>, <https://nuclide.cc/technologies/fdg-pet/>, <https://nuclide.cc/targets/fap/> ;
  nuclide:pipeline <https://nuclide.cc/opportunities/opp-cldn18-2-imaging-gastric/>, <https://nuclide.cc/targets/cldn18-2/>, <https://nuclide.cc/targets/her2/>, <https://nuclide.cc/technologies/fdg-pet/> .